Article Details

Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics

Retrieved on: 2019-04-10 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics. View article details on hiswai:

Excerpt

<div>Pandion was founded in 2017 and closed a $58M Series A financing round in early 2018 with funding from <b>Polaris Partners</b>, Versant Ventures, Roche ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo